» Authors » Martin C Robson

Martin C Robson

Explore the profile of Martin C Robson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 928
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Ching Y, Sutton T, Pierpont Y, Robson M, Payne W
Eplasty . 2011 Nov; 11:e41. PMID: 22084646
Objective: Certain cytokines, especially those known as growth factors, have been demonstrated to mediate or modulate burn wound healing. Experimental and clinical evidence suggests that there are therapeutic advantages to...
12.
Uberti M, Lufkin A, Pierpont Y, Ko F, Smith C, Robson M, et al.
Ann Plast Surg . 2011 Apr; 66(5):575-80. PMID: 21451377
Activated macrophages play a significant role in wound healing and infected tissue repair. In this study, we investigate the recruitment of macrophages into the wound, and the effects on the...
13.
Wang L, Belisle B, Bassiri M, Xu P, Debabov D, Celeri C, et al.
Antimicrob Agents Chemother . 2011 Mar; 55(6):2688-92. PMID: 21422212
During oxidative burst, neutrophils selectively generate HOCl to destroy invading microbial pathogens. Excess HOCl reacts with taurine, a semi-essential amino acid, resulting in the formation of the longer-lived biogenerated broad-spectrum...
14.
Xing L, Culbertson E, Wen Y, Robson M, Franz M
Obes Surg . 2011 Feb; 21(12):1937-46. PMID: 21347822
Background: Obesity increases the risk of laparotomy dehiscence and incisional hernia. The aim of this study was to measure the biological effect of obesity on laparotomy wound healing and the...
15.
Johnson E, Pierpont Y, Donate G, Hiro M, Mannari R, Strickland T, et al.
Int Wound J . 2011 Feb; 8(2):163-8. PMID: 21310005
Kaposi's sarcoma (KS) typically presents as multiple bilateral cutaneous patches or plaques of the lower extremities. This malignancy, however, can evolve with atypical presentation masquerading as a chronic wound. Lesions...
16.
Payne W, Bhalla R, Hill D, Pierpont Y, Robson M
Eplasty . 2011 Jan; 11:e1. PMID: 21245984
Background: Wound healing trajectories (percent healing vs time) provide a dynamic picture of the decrease in wound burden over the entire continuum of the healing process. Trajectories can be robustly...
17.
Pierpont Y, Uberti M, Ko F, Robson M, Smith C, Wright T, et al.
Am J Surg . 2010 Dec; 202(2):220-4. PMID: 21185550
Background: The use of biologic markers to aid in individualizing wound treatment may help improve outcomes. A biologic marker that has been demonstrated to be predictive of healing in both...
18.
Uberti M, Pierpont Y, Ko F, Wright T, Smith C, Cruse C, et al.
Ann Plast Surg . 2010 Apr; 64(5):632-5. PMID: 20395817
Amnion-derived Multipotent Progenitor cells appear to be useful as adjuvants in wound healing. Amnion-derived multipotent progenitor cells secrete a unique combination of cytokines and growth factors, known as amnion-derived cellular...
19.
Payne W, Wachtel T, Smith C, Uberti M, Ko F, Robson M
World J Surg . 2010 Feb; 34(7):1663-8. PMID: 20127332
Background: Amnion-derived multipotent progenitor (AMP) cells, unlike most stem cells, have been demonstrated to be nontumorigenic and nonimmunogenic. Amnion-derived cellular cytokine solution (ACCS), a secreted product of AMP cells, is...
20.
Bergmann J, Hackl F, Koyama T, Aflaki P, Smith C, Robson M, et al.
Eplasty . 2009 Nov; 9:e49. PMID: 19936023
Objective: The purpose of this study was to determine whether amnion-derived cellular cytokine solution (ACCS) could improve the quality of epithelialization and accelerate closure of dermatome-created partial-thickness wounds in normal...